resisttb
- Dec 1, 2021
- 1 min read

Global individual patient data platform for drug-resistant tuberculosis treatment

In order to increase the knowledge base for normative guidance on optimal treatment modalities for drug-resistant tuberculosis (DR-TB), WHO is announcing a publicly accessible global individual patient data (IPD) platform for drug-resistant tuberculosis treatment (DR-TB-IPD). This will be a secure but accessible platform containing outcomes of over 10,000 drug-resistant TB patients as the starting point and expanding this with data received in response to a recent public call for data. Read Here.

Recent Posts

See All

John Green & Grassroots Activists Pressure Danaher To Drop Price of Tuberculosis Test

“Why am I passionate about TB? It’s the deadliest disease in human history, but for most of human history we couldn’t do much about it. However, since the mid-1950s, TB has been curable — yet we still

Barely Contained Rage: An Open Letter to Danaher and Cepheid

"Danaher and Cepheid are using a printer-ink business model to overcharge for tuberculosis tests, thus resulting in millions of people going undiagnosed every year, many of whom will die." Watch the f

What’s new in the TB section of the 2023 WHO Model Lists of Essential Medicines

The World Health Organization’s (WHO’s) 2023 Model Lists of Essential Medicines, published in July 2023, features key updates to the tuberculosis (TB) section. These complement current WHO recommendat